Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Return on Sales (2016 - 2025)

Historic Return on Sales for Aytu Biopharma (AYTU) over the last 17 years, with Q4 2025 value amounting to 0.0%.

  • Aytu Biopharma's Return on Sales fell 100.0% to 0.0% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.0%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.01% for FY2025, which is 600.0% up from last year.
  • As of Q4 2025, Aytu Biopharma's Return on Sales stood at 0.0%, which was down 100.0% from 0.0% recorded in Q3 2025.
  • In the past 5 years, Aytu Biopharma's Return on Sales ranged from a high of 0.02% in Q3 2024 and a low of 2.2% during Q1 2022
  • Over the past 5 years, Aytu Biopharma's median Return on Sales value was 0.06% (recorded in 2023), while the average stood at 0.4%.
  • Its Return on Sales has fluctuated over the past 5 years, first crashed by -12300bps in 2021, then soared by 18900bps in 2023.
  • Over the past 5 years, Aytu Biopharma's Return on Sales (Quarter) stood at 0.5% in 2021, then skyrocketed by 49bps to 0.25% in 2022, then skyrocketed by 82bps to 0.04% in 2023, then soared by 117bps to 0.01% in 2024, then plummeted by -76bps to 0.0% in 2025.
  • Its Return on Sales was 0.0% in Q4 2025, compared to 0.0% in Q3 2025 and 0.0% in Q2 2025.